GRACEcast ALL Subjects audio and video
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Duración: 0:19:29
- Mas informaciones
Informações:
Sinopsis
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
